Growth Metrics

Nu-Med Plus (NUMD) EBT Growth (1y) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.50%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 11.26%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -8.83%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 44.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 5.78%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 103.34%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 74.66%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -27.02%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 54.33%
10 Nu-Med Plus - - - -19.55%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -19.55%
Sep 30, 2025 35.93%
Jun 30, 2025 32.52%
Mar 31, 2025 8.67%
Dec 31, 2024 81.35%
Sep 30, 2024 -13.84%
Jun 30, 2024 28.92%
Mar 31, 2024 22.61%
Dec 31, 2023 -232.84%
Sep 30, 2023 71.74%
Jun 30, 2023 58.12%
Mar 31, 2023 52.72%
Dec 31, 2022 137.93%
Sep 30, 2022 50.96%
Jun 30, 2022 76.96%
Mar 31, 2022 83.28%
Dec 31, 2021 77.87%
Sep 30, 2021 73.92%
Jun 30, 2021 72.38%
Mar 31, 2021 -132.66%
Dec 31, 2020 -141.90%
Sep 30, 2020 -201.39%
Jun 30, 2020 -281.18%
Mar 31, 2020 63.43%
Dec 31, 2019 40.10%
Sep 30, 2019 70.89%
Jun 30, 2019 -46.08%
Mar 31, 2019 -204.75%
Dec 31, 2018 -108.98%
Sep 30, 2018 -290.35%
Jun 30, 2018 -53.79%
Mar 31, 2018 -109.00%
Dec 31, 2017 315.52%
Sep 30, 2017 80.80%
Jun 30, 2017 38.21%
Mar 31, 2017 -9.44%
Dec 31, 2016 15.14%
Sep 30, 2016 -130.58%
Jun 30, 2016 55.25%
Mar 31, 2016 47.59%
Dec 31, 2015 255.05%
Sep 30, 2015 -27.43%
Jun 30, 2015 -98.28%
Mar 31, 2015 20.51%
Sep 30, 2014 -603.47%
Jun 30, 2014 -524.09%
Mar 31, 2014 -84.18%
Mar 31, 2013 -301.22%